Supplementary Video S2B from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma

Supplementary Video S2B from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma

<p>40 min full dynamic Total-body PET imaging of Patient 8</p>

Spremljeno u:

Bibliografski detalji
Glavni autor:	Xiaojiang Duan (15439264) (author)
Daljnji autori:	Lei Xia (15439267) (author), Zhuochen Zhang (15439270) (author), Yanan Ren (15439273) (author), Martin G. Pomper (10938220) (author), Steven P. Rowe (10938217) (author), Xuesong Li (15439276) (author), Nan Li (15276704) (author), Ning Zhang (15439279) (author), Hua Zhu (15439282) (author), Zhi Yang (15439285) (author), Xinan Sheng (15030377) (author), Xing Yang (15439288) (author)
Izdano:	2025
Teme:	Cancer Cancer Detection and Diagnosis Therapeutic Research and Development Methods and Technology Biomarkers Imaging biomarkers Clinical Imaging Genitourinary Cancers Bladder cancer Imaging Imaging probes Positron emission tomography (PET) Translational Research
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!

Slični predmeti

Supplementary Video S1 from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
od: Xiaojiang Duan (15439264)
Izdano: (2025)

Supplementary Video S2A from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
od: Xiaojiang Duan (15439264)
Izdano: (2025)

Supplementary Video S2C from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
od: Xiaojiang Duan (15439264)
Izdano: (2025)

Figure 1 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
od: Friederike Hesse (14958870)
Izdano: (2025)

Figure 2 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
od: Friederike Hesse (14958870)
Izdano: (2025)

Figure 3 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
od: Friederike Hesse (14958870)
Izdano: (2025)

Figure 4 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
od: Friederike Hesse (14958870)
Izdano: (2025)

Figure 5 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
od: Friederike Hesse (14958870)
Izdano: (2025)

Figure 6 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
od: Friederike Hesse (14958870)
Izdano: (2025)

Figure 7 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
od: Friederike Hesse (14958870)
Izdano: (2025)

Table 1 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
od: Friederike Hesse (14958870)
Izdano: (2025)

Figure 1 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
od: Vinton W.T. Cheng (15020397)
Izdano: (2025)

Figure 2 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
od: Vinton W.T. Cheng (15020397)
Izdano: (2025)

Figure 3 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
od: Vinton W.T. Cheng (15020397)
Izdano: (2025)

Figure 4 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
od: Vinton W.T. Cheng (15020397)
Izdano: (2025)

Figure 5 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
od: Vinton W.T. Cheng (15020397)
Izdano: (2025)

Figure 6 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
od: Vinton W.T. Cheng (15020397)
Izdano: (2025)

Supplementary Video from Shortwave Infrared Imaging Enables High-Contrast Fluorescence-Guided Surgery in Neuroblastoma
od: Laura Privitera (16015972)
Izdano: (2025)

Data Sheet 1_Intra-voxel incoherent motion biomarker repeatability in healthy volunteers and sensitivity to chemoradiotherapy-induced changes in patients with uterine cervical cancer.pdf
od: Damien J. McHugh (22686269)
Izdano: (2025)

Figure 1 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models
od: Isabel Quiros-Gonzalez (14952835)
Izdano: (2025)

Figure 2 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models
od: Isabel Quiros-Gonzalez (14952835)
Izdano: (2025)

Figure 3 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models
od: Isabel Quiros-Gonzalez (14952835)
Izdano: (2025)

Figure 4 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models
od: Isabel Quiros-Gonzalez (14952835)
Izdano: (2025)

Figure 5 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models
od: Isabel Quiros-Gonzalez (14952835)
Izdano: (2025)

Supplementary Data from Active Remodeling of Capillary Endothelium via Cancer Cell–Derived MMP9 Promotes Metastatic Brain Colonization
od: Matthia A. Karreman (15097355)
Izdano: (2025)

Supplementary Data from Active Remodeling of Capillary Endothelium via Cancer Cell–Derived MMP9 Promotes Metastatic Brain Colonization
od: Matthia A. Karreman (15097355)
Izdano: (2025)

Supplementary Data from Active Remodeling of Capillary Endothelium via Cancer Cell–Derived MMP9 Promotes Metastatic Brain Colonization
od: Matthia A. Karreman (15097355)
Izdano: (2025)

Supplementary Data from Active Remodeling of Capillary Endothelium via Cancer Cell–Derived MMP9 Promotes Metastatic Brain Colonization
od: Matthia A. Karreman (15097355)
Izdano: (2025)

Supplementary Data from Active Remodeling of Capillary Endothelium via Cancer Cell–Derived MMP9 Promotes Metastatic Brain Colonization
od: Matthia A. Karreman (15097355)
Izdano: (2025)

Supplementary Data from Active Remodeling of Capillary Endothelium via Cancer Cell–Derived MMP9 Promotes Metastatic Brain Colonization
od: Matthia A. Karreman (15097355)
Izdano: (2025)

Supplementary Figure 1 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
od: Michelle L. Mierzwa (14963463)
Izdano: (2025)

Textural changes are more sensitive than volumetry of amygdala in cocaine use disorder patients: potential for low field translation
od: Shounak Nandi (22675916)
Izdano: (2025)

Table S1 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases
od: Noor Jailkhani (16015810)
Izdano: (2025)

Table S2 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases
od: Noor Jailkhani (16015810)
Izdano: (2025)

Table S3 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases
od: Noor Jailkhani (16015810)
Izdano: (2025)

Video 1_Imaging-driven diagnosis of retroperitoneal psoas major alveolar soft part sarcoma: a case report.mp4
od: Shasha Wei (1555588)
Izdano: (2025)

FigureS1 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
od: Jonathan Chou (14957015)
Izdano: (2025)

FigureS10 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
od: Jonathan Chou (14957015)
Izdano: (2025)

FigureS2 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
od: Jonathan Chou (14957015)
Izdano: (2025)

FigureS3 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
od: Jonathan Chou (14957015)
Izdano: (2025)

Cannot write session to /tmp/vufind_sessions/sess_rehbo0esu8jb5jq3tnbcoogrpp